Found 276 matching trials
Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer PHASE1 Study to determine the best dose of stereotactic body radiation therapy (SB...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma PHASE1 This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part.
...
Show More Location
Multiple Locations
Learn More & Join Trial
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. PHASE1 The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Show More Location
National University Hospital
Learn More & Join Trial
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma PHASE2 This is a prospective, monocenter, single arm, phase II trial in 33 patient...
Show More Location
Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis
Learn More & Join Trial
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer N/A Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Show More Location
Hunan Cancer hospital
Learn More & Join Trial
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study NA This study is looking at outcomes in people with advanced cancers who have ...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) PHASE2 The purpose of this study is to investigate the characteristics of tumors i...
Show More Location
University of Connecticut Health Center
Learn More & Join Trial
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients PHASE2 A one-arm, single center phase 2 trial of SAbR plus ipilimumab plus nivolum...
Show More Location
University of Texas Southwestern Medical Center - Dallas
Learn More & Join Trial
Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis PHASE1 Melanoma is the deadliest form of skin cancer and its incidence has doubled...
Show More Location
Clinique Dermatologique/Radiologie Interventionnelle/Urologie/Gynécologie-CHU de Strasbourg/ICANS
Learn More & Join Trial
Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response PHASE4 Patients with advanced melanoma are, amongst others, currently treated with...
Show More Learn More & Join Trial